skip to main content

Research + Education

The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.

News

  • 4 Rogel Cancer Center members named AAAS fellows

    Four Rogel Cancer Center members earned election to the American Association for the Advancement of Science in 2024. The AAAS is the world’s largest general scientific society. Fellows are elected for their “efforts on behalf of the advancement of science, or its applications, are scientifically or socially distinguished.”
    Read More >
  • Lighting up cancer cells with biolasers

    Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients. As tumors develop, they shed cells into the bloodstream. Although these circulating tumor cells are vastly outnumbered by millions of other blood cells, detecting them early can potentially improve treatment outcomes.
    Read More >
  • How breast cancer cells survive in bone marrow after remission

    A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. The paper, “Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels,” appears in the Journal of Clinical Investigation.
    Read More >
  • Enzyme identified as new therapeutic target for “cold” tumors

    Drugs that suppress UBA1 could make immune checkpoint blocking immunotherapy effective for patients with prostate cancer and other “cold” tumors
    Read More >